Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | TACR3 | P29371 | 11/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.31 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26601306 | 1.00 | NPC1 (0.36) | NPC1RAB9ATACR3SMN1; SMN2HCRTR1 | |
| SCHEMBL26633209 | 0.90 | NPC1 (0.38) | NPC1RAB9ATACR3SMN1; SMN2HCRTR1 | |
| SCHEMBL30623696 | 0.90 | NPC1 (0.38) | NPC1RAB9ATACR3SMN1; SMN2HCRTR1 | |
| SCHEMBL31457355 | 0.90 | NPC1 (0.38) | NPC1RAB9ATACR3SMN1; SMN2HCRTR1 | |
| SCHEMBL31675990 | 0.84 | MAPT (0.39) | SMN1; SMN2HDAC3HDAC1 | |
| SCHEMBL26601318 | 0.79 | HDAC3 (0.44) | NPC1RAB9ASMN1; SMN2HCRTR1HDAC3 | |
| SCHEMBL26601331 | 0.78 | LMNA (0.34) | SMN1; SMN2HDAC3HDAC1 | |
| SCHEMBL26601327 | 0.78 | LMNA (0.34) | SMN1; SMN2HDAC3HDAC1 | |
| SCHEMBL31461704 | 0.73 | RAB9A (0.44) | NPC1RAB9ASMN1; SMN2HCRTR1HDAC3 | |
| SCHEMBL26601384 | 0.70 | SMN1; SMN2 (0.39) | NPC1RAB9ASMN1; SMN2HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023205219-A1 | PROTEOLYSIS TARGETING CHIMERA (PROTAC) COMPOSITIONS USING UBIQUITIN CONJUGATING ENZYME LIGANDS | BERG LLC (US) | 2023-10-26 | — | — | WO | disclosed |